S2 Ep68: From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
On Chen, MD, and Tahmid Rahman, MD discuss how plozasiran—an RNA-based APOC3-targeting therapy for patients with familial chylomicronemia syndrome with infrequent injections and a favorable safety profile—can transform care when integrated through coordinated multidisciplinary workflows with pharmacists leading patient identification, access, and monitoring.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.